Canada

GSK's Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada – Financial Times

GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada  Financial Times